Integrative Clinical and DNA Methylation Analyses in a Population-Based Cohort Identifies CDH17 and LRP2 as Risk Recurrence Factors in Stage II Colon Cancer.
Saved in:
| Title: | Integrative Clinical and DNA Methylation Analyses in a Population-Based Cohort Identifies CDH17 and LRP2 as Risk Recurrence Factors in Stage II Colon Cancer. |
|---|---|
| Authors: | Tournier B; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France.; Department of Pathology, Dijon University Hospital, 21000 Dijon, France., Aucagne R; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France.; Unit for Innovation in Genetics and Epigenetics in Oncology (IGEO) and CRIGEN (Crispr Functional Genomics), Dijon University Hospital, 21000 Dijon, France.; Genetics and Immunology Medical Institute (GIMI), 21000 Dijon, France., Truntzer C; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France.; Unit for Innovation in Genetics and Epigenetics in Oncology (IGEO) and CRIGEN (Crispr Functional Genomics), Dijon University Hospital, 21000 Dijon, France.; Centre Georges-François Leclerc (CGFL), 21000 Dijon, France., Fournier C; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France.; Unit for Innovation in Genetics and Epigenetics in Oncology (IGEO) and CRIGEN (Crispr Functional Genomics), Dijon University Hospital, 21000 Dijon, France.; Genetics and Immunology Medical Institute (GIMI), 21000 Dijon, France., Ghiringhelli F; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France.; Unit for Innovation in Genetics and Epigenetics in Oncology (IGEO) and CRIGEN (Crispr Functional Genomics), Dijon University Hospital, 21000 Dijon, France.; Genetics and Immunology Medical Institute (GIMI), 21000 Dijon, France.; Centre Georges-François Leclerc (CGFL), 21000 Dijon, France., Chapusot C; Department of Pathology, Dijon University Hospital, 21000 Dijon, France., Martin L; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France.; Department of Pathology, Dijon University Hospital, 21000 Dijon, France., Bouvier AM; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France., Manfredi S; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France.; Department of Hepato-Gastroenterology and Digestive Oncology, Dijon University Hospital, 21000 Dijon, France., Jooste V; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France.; Department of Hepato-Gastroenterology and Digestive Oncology, Dijon University Hospital, 21000 Dijon, France., Callanan MB; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France.; Unit for Innovation in Genetics and Epigenetics in Oncology (IGEO) and CRIGEN (Crispr Functional Genomics), Dijon University Hospital, 21000 Dijon, France.; Genetics and Immunology Medical Institute (GIMI), 21000 Dijon, France., Lepage C; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France.; Department of Hepato-Gastroenterology and Digestive Oncology, Dijon University Hospital, 21000 Dijon, France. |
| Source: | Cancers [Cancers (Basel)] 2022 Dec 27; Vol. 15 (1). Date of Electronic Publication: 2022 Dec 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2072-6694 |
|---|---|
| DOI: | 10.3390/cancers15010158 |
